Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of IMOD in the treatment of acute ischemic stroke
IRCT201108202195N2Phase 3Completed
- Sponsor
- Research Deputy of Tabriz University of Medical Sciences
- Start
- Oct 2011
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of IMOD in ischemic stroke, sponsored by Research Deputy of Tabriz University of Medical Sciences. Started Oct 2011; status: completed.
02
Drugs
IMOD
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on IRCT201108202195N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201108202195N2.